Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 15, 2023 - Issue
Submit an article Journal homepage
206
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United States

Lita Araujo1 Neurology and Immunology, Sanofi, Cambridge, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6863-9340View further author information
ORCID Icon,
Srikanth Kyatham2 Axtria Inc, Berkeley Heights, NJ, USAView further author information
,
Kristen G Bzdek1 Neurology and Immunology, Sanofi, Cambridge, MA, USAView further author information
,
Keiko Higuchi1 Neurology and Immunology, Sanofi, Cambridge, MA, USAView further author information
&
Nupur Greene1 Neurology and Immunology, Sanofi, Cambridge, MA, USAView further author information
Pages 361-373 | Received 27 Jan 2023, Accepted 02 May 2023, Published online: 20 May 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.